UNSPSC 51332807: Chlorpromazine

This classification denotes a phenothiazine and antipsychotic agent with the molecular formula C17H19ClN2S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier U42B7VYA4P, chemically known as 10h-phenothiazine-10-propanamine, 2-chloro-n,n-dimethyl-, radical ion(1+) but generally known as chlorpromazine, which bears US NIH Compound Identifier 2726. European Medicines Agency schedules Chlorpromazine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06208MIG.

UNSPSC 51332807 Chlorpromazine is a Commodity code that identifies a specific pharmaceutical product, but state and local procurement records tagged under this code show minimal recent activity directly aligned with chlorpromazine acquisition itself. The single recent opportunity in the dataset—Seminole County, Florida's IFB60459723LAS—is actually for naloxone and drug deactivation systems, not chlorpromazine, indicating either a misclassification in the county's procurement tagging or a tangential pharmaceutical-supply relationship. State and local health departments, county health agencies, and emergency services use this code tier for targeted pharmaceutical procurements tied to public health initiatives, drug overdose response programs, and community health infrastructure, though the volume of activity under this specific commodity code remains limited.

Seminole County released its IFB for naloxone and drug deactivation systems on June 30, 2026, with a response deadline of July 26, 2026, seeking 1,900 units of naloxone and 800 deactivation systems annually on a two-year term with optional one-year renewal. Delivery is required to the Seminole County Community Health Building in Sanford, Florida, on a quarterly schedule, with all shipping costs to be included in bids. The procurement does not specify set-aside designations and requires E-Verify compliance, drug-free workplace certification, and standard insurance coverage including workers' compensation and commercial general liability. No additional state or local opportunities under the chlorpromazine code are present in the recent data. The limited activity and the subject-matter mismatch between the code name and the opportunity sourced suggest this code represents either dormant procurement or a specialized therapeutic category with infrequent state and local demand.